Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors. Clin Pharmacol Drug Dev. 2014 07; 3(4):284-9.
View in:
PubMed
subject areas
Action Potentials
Action Potentials
Angiogenesis Inhibitors
Angiogenesis Inhibitors
Arrhythmias, Cardiac
Arrhythmias, Cardiac
Cardiotoxicity
Cardiotoxicity
Electrocardiography
Electrocardiography
Female
Female
Heart Conduction System
Heart Conduction System
Heart Rate
Heart Rate
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Neoplasms
Neoplasms
Phenylurea Compounds
Phenylurea Compounds
Prospective Studies
Prospective Studies
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Quinolines
Quinolines
Risk Assessment
Risk Assessment
Treatment Outcome
Treatment Outcome
authors with profiles
Kathleen Moore